Cover Image

PAPERBACK
$43.50



View/Hide Left Panel

Parasitic, Bacterial, and Viral Diseases, R.M.Lerner, R.M.Chanock, and F.Brown, eds. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.


Douglas, R.M., and E.Kerby-Eaton, eds. 1985. Acute Respiratory Infections in Childhood. Proceedings of an International Workshop, Sydney, Australia, August 1984. Sydney: University of Adelaide.


Fulginiti, V.A., J.J.Eller, O.F.Sieber, J.W.Joyner, M.Minamitani, and G.Meiklejohn. 1969. Respiratory virus immunization, I. A field trial of two inactivated respiratory virus vaccines: An aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus infection. Am. J. Epidemiol. 89:435–448.


Garvie, D.G., and J.Gray. 1980. Outbreak of respiratory syncytial virus infection in the elderly. Brit. Med. J. 281:1253–1254.

Gharpure, M.A., P.F.Wright, and R.M.Chanock. 1969. Temperature-sensitive mutants of respiratory syncytial virus. J.Virol. 3:414–421.

Glezen, W.P. 1984. Reactive airway disorders in children: Role of respiratory virus infections. Clin. Chest Med. 5:635–644.

Glezen, W.P., A.Paredes, J.E.Allison, L.H.Taber, and A.L.Frank. 1981. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J. Pediatr. 98(5):708–715.


Hall, C.B., J.T.McBride, E.E.Walsh, D.M.Bell, C.L.Gala, S.Hildreth, L.G. ten Eyck, and W.J.Hall. 1983. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. A randomized double-blind study. N. Engl. J. Med. 308(24):1443–1447.

Henderson, F.W., A.M.Collier, Jr., W.A.Clyde, and F.W.Denny. 1979. Respiratory-syncytial virus infection, reinfection and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 300(10):530–534.


Kapikian, A.Z., R.H.Mitchell, R.M.Chanock, R.A.Shvedoff, and C.E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405–421.

Kim, H.W., J.G.Canchola, C.D.Brandt, G.Pyles, R.M.Chanock, K. Jensen, and R.H.Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J.Epidemiol. 89:422–434.

Kim, H.W., J.O.Arrobio, C.D.Brandt, P.Wright, D.Hodes, R.M. Chanock, and R.H.Parrott. 1973. Safety and antigenicity of temperature sensitive (ts) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics 52:56–63.


MacDonald, N.E., C.B.Hall, S.C.Suffin, C.Alexson, P.J.Harris, and J.A.Manning. 1982. Respiratory syncytial virus infection in infants with congenital heart disease. N. Engl. J. Med. 307(7):397–400.

Mills, J., J.E.VanKirk, P.F.Wright, and R.M.Chanock. 1971. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 107:123–130.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement